How I treat hairy cell leukemia

Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia

1984 • 833 citations

Leukemic Reticuloendotheliosis

1958 • 542 citations

Lasting Remissions in Hairy-Cell Leukemia Induced by a Single Infusion of 2-Chlorodeoxyadenosine

1990 • 521 citations

Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011

2004 • 417 citations

Long-Term Follow-Up of Patients With Hairy Cell Leukemia After Cladribine Treatment

1998 • 318 citations

Extended Follow-Up of Patients With Hairy Cell Leukemia After Treatment With Cladribine

2003 • 273 citations

Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.

1995 • 268 citations

Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis

2009 • 251 citations

Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1)

2004 • 243 citations

2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia

1994 • 211 citations

Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.

2000 • 170 citations

Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin).

1984 • 166 citations

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)

1992 • 154 citations

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience

2005 • 139 citations

Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up.

1997 • 134 citations

Eradication of minimal residual disease in hairy cell leukemia

2006 • 126 citations

Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections

1992 • 120 citations

A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia

1992 • 120 citations

Long remissions in hairy cell leukemia with purine analogs

2005 • 110 citations

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

2003 • 107 citations

Low-dose deoxycoformycin in the treatment of hairy cell leukemia

1986 • 107 citations

Recombinant Immunotoxins Containing Truncated Bacterial Toxins for the Treatment of Hematologic Malignancies

2009 • 104 citations

Immunosuppressive effects of pentostatin.

1990 • 99 citations

2-Chlorodeoxyadenosine: A Newer Purine Analog Active in the Treatment of Indolent Lymphoid Malignancies

1994 • 98 citations

Second Cancer Incidence and Cause-Specific Mortality Among 3104 Patients With Hairy Cell Leukemia: A Population-Based Study

2007 • 98 citations

Efficacy of 2'-Deoxycoformycin in Hairy-Cell Leukemia: A Study of the National Cancer Institute of Canada Clinical Trials Group1

1988 • 91 citations

Non-traumatic splenic rupture: Report of seven cases and review of the literature

2008 • 89 citations

Long-term follow-up of patients with hairy cell leukemia after treatment with 2'-deoxycoformycin

1994 • 89 citations

Immunophenotyping and Differential Diagnosis of Hairy Cell Leukemia

2006 • 86 citations

Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.

1999 • 81 citations

Current treatment options in hairy cell leukemia and hairy cell leukemia variant

2006 • 78 citations

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial

2007 • 71 citations

Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine.

2004 • 68 citations

Clinical staging system for hairy-cell leukemia

1982 • 62 citations

Filgrastim for Cladribine-Induced Neutropenic Fever in Patients With Hairy Cell Leukemia

1999 • 62 citations

The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia

2007 • 53 citations

Hairy Cell Leukemia: Diagnostic Pathology

2006 • 51 citations

Potential Predictive Patterns of Minimal Residual Disease Detected by Immunohistochemistry on Bone Marrow Biopsy Specimens During a Long-term Follow-up in Patients Treated With Cladribine for Hairy Cell Leukemia

2006 • 44 citations

Somatic hypermutation and VH gene usage in hairy cell leukaemia

2006 • 43 citations

CD52 expression in hairy cell leukemia

2003 • 43 citations

Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.

1999 • 42 citations

Clinical Presentations and Complications of Hairy Cell Leukemia

2006 • 39 citations

Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia

2008 • 36 citations

Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.

2000 • 35 citations

High density genome‐wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia

2008 • 35 citations

Randomized trial of dailyversusweekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98)

2009 • 34 citations

Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood. 1958;13(7):609-630.

2016 • 34 citations

Hairy Cell Leukemia: Treatment Successes in the Past 25 Years

2008 • 34 citations

Risk factors for severe infection in patients with hairy cell leukemia: a long‐term study of 73 patients

2009 • 34 citations

Integrated genetic and physical map of the 1q31→q32.1 region, encompassing the RP12 locus, the F13B and HF1 genes, and the EEF1AL11 and RPL30 pseudogenes

1999 • 30 citations

Long‐term follow‐up of interferon‐alpha induction and low‐dose maintenance therapy in hairy cell leukemia

2008 • 29 citations

Soluble CD22 as a tumor marker for hairy cell leukemia

2008 • 28 citations

Infections associated with purine analogs and monoclonal antibodies

2005 • 26 citations

Hairy cell leukemia: lessons learned in twenty-five years.

1983 • 26 citations

Immunotoxins in the Treatment of Refractory Hairy Cell Leukemia

2006 • 23 citations

Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia.

1998 • 20 citations

Sweet syndrome as the presenting symptom of hairy cell leukemia

2009 • 19 citations

Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2‐chlorodeoxyadenosine therapy

2001 • 16 citations

Cladribine in Hairy Cell Leukemia

2006 • 11 citations

Splenectomy, Interferon, and Treatments of Historical Interest in Hairy Cell Leukemia

2006 • 11 citations

Pentostatin: Impact on Outcome in Hairy Cell Leukemia

2006 • 10 citations

SPONTANEOUS SPLENIC RUPTURE IN TWO PATIENTS WITH HEMATOLOGIC MALIGNANCY

2007 • 10 citations

Biological markers and minimal residual disease in hairy cell leukemia.

1992 • 10 citations

Aplastic anemia terminating in hairy cell leukemia. A report of two cases

1984 • 10 citations

Monoclonal Antibody Therapy for Hairy Cell Leukemia

2006 • 9 citations

Purine Analogues: Rationale for Development, Mechanisms of Action, and Pharmacokinetics in Hairy Cell Leukemia

2006 • 9 citations

Hairy cell leukemia

2007 • 9 citations

Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia.

1996 • 8 citations

Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).

1993 • 4 citations

Autologous "foreign body" as a sequel of improper cutting of an ingrowing toe nail?

2009 • 3 citations

Clinical staging system for hairy-cell leukemia

1982 • 2 citations